|
Status |
Public on Feb 13, 2019 |
Title |
Next Generation Sequencing Facilitates Quantitative Analysis of ischemic postconditioning (IPO) to attenuate hepatic ischemia-reperfusion injury in mice |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
This is the first study to investigate mRNA expression profiling in regard to hepatic I/R and IPO by next-generation RNA-Seq. Our results may provide an experimental basis for elucidating the underlying mechanism of IPO and reveal candidate biomarkers with which to assess hepatic I/R injury
|
|
|
Overall design |
liver mRNA profiles of sham, I/R and IPO mice were generated by next-generation sequencing, in triplicate, using Illumina HiSeq 4000.
|
|
|
Contributor(s) |
Ye Q, Zhang P |
Citation(s) |
30745817 |
|
Submission date |
Jul 13, 2018 |
Last update date |
Mar 19, 2019 |
Contact name |
Pengpeng Zhang |
E-mail(s) |
yqf_china@126.com
|
Phone |
15116256469
|
Organization name |
The Third Xiangya Hospital of Central South University
|
Street address |
No.138 Tongzipo Road
|
City |
Changsha |
State/province |
Hunan |
ZIP/Postal code |
410013 |
Country |
China |
|
|
Platforms (1) |
GPL21103 |
Illumina HiSeq 4000 (Mus musculus) |
|
Samples (9)
|
|
Relations |
BioProject |
PRJNA481000 |
SRA |
SRP153358 |